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CFHealthHub: Complex intervention to support adherence to treatment in adults with cystic 
fibrosis: external pilot trial 
 
D. Hind1, C. Maguire1, H. Cantrill1, A. O'Cathain2, M. Wildman3, for the CFHealthHub group 
 
1University of Sheffield, Sheffield Clinical Trials Research Unit, Sheffield, United Kingdom, 2University 
of Sheffield, School of Health and Related Research (ScHARR), Sheffield, United Kingdom, 3Sheffield 
Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom 
 
Objectives: 
Test processes for / feasibility of a full-scale RCT evaluating CFHealthHub (CFHH) a theory-based 
FRPSOH[LQWHUYHQWLRQWHVWWKHDFFHSWDELOLW\RI&)++ 
 
Methods: 
Design: Non-blinded, pilot, parallel-group RCT (ISRCTN13076797). 
 
3DUWLFLSDQWV3HRSOHZLWK&)DWWZRXQLWV(OLJLEOHDJHGRQ8.UHJLVWU\ willing to take inhaled 
mucolytics and antibiotics via a chipped nebuliser. Those post lung transplant or on the active lung 
transplant list, unable to give informed consent or using dry powder inhalers are excluded. 
 
Interventions: (1) collection / feedback of adherence data via chipped nebuliser and software platform, 
with strategies to empower self-management delivered online and in six face-to-face meetings over 
5m with trainHGLQWHUYHQWLRQLVWVQ XVXDOFDUHQ  
 
Primary outcome: Feasibility of RCT defined as: (1) recruitment of >48 participants (75% of target) in 
IRXUPRQWKVYDOLGSULPDU\RXWFRPHGDWDIRU!RIWKRVHUDQGRmised. Key clinical outcome: 
number of pulmonary exacerbations in a five-month period (Fuchs criteria). 
 
Randomisation: 1:1 allocation via centralised web-based randomisation system, stratified by centre 
and days on intravenous antibiotics in previous year 
 
Results: 
Between 13/06/16 and 30/09/16, 64 participants were randomised to CFHH (n=31) or control (n=33) 
mean rate 4 per week. One unexpected serious adverse event was unrelated to CFHH. Retention 
rates, intervention acceptability and process data will be available by 31/03/2017. 
 
Conclusion: 
Recruitment to a full-scale trial is feasible. 
